Michael Kruer
Neurodevelopmental Disabilities · Phoenix, AZNPI 1366640468
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $44,275 of the $73,274 with a category attached, or 60.4%. PTC Therapeutics, Inc. accounts for 67.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $35,361 and has fallen 77.5% since, to $7,963 in 2024.
Across 93 payments — averaging $787.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- PTC Therapeutics, Inc.$49K
- Neurocrine Biosciences, Inc.$16K
- Acadia Pharmaceuticals Inc$4K
- Merz Pharmaceuticals, LLC$4K
- Immedica Pharma US, Inc.$103
- UCB, Inc.$75
- plus $144 from 6 others
Across 41 payments — averaging $2058.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- PTC Therapeutics, Inc.$44K
- Teva Pharmaceuticals USA, Inc.$40K
What the payments were for
- Consulting fees$24,53833%
- Speaking & faculty fees$44,27560%
- Travel & lodging$3,3965%
- Food & beverage$1,0521%
- Education$130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| PTC Therapeutics, Inc. | 56 | $49,172 |
| Neurocrine Biosciences, Inc. | 8 | $16,348 |
| Acadia Pharmaceuticals Inc | 5 | $3,844 |
| Merz Pharmaceuticals, LLC | 1 | $3,588 |
| Immedica Pharma US, Inc. | 3 | $103 |
| UCB, Inc. | 3 | $75 |
| Sunovion Pharmaceuticals Inc. | 2 | $40 |
| Eisai Inc. | 2 | $34 |
| Orphalan Inc | 1 | $27 |
| Neurelis, Inc. | 1 | $16 |
| Amgen | 1 | $15 |
| Travere Therapeutics, Inc. | 10 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few neurodevelopmental disabilities providers in Arizonato place this figure against a meaningful peer group, so we don't.
Other neurodevelopmental disabilities in Phoenix
- David HirschPhoenix$14
- Deborah CalhounScottsdale$128
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.